ANURAS

🧪 | On the Growth Track

📉 Q4 FY24 profit fell 44% YoY to ₹40.4 Cr; revenue at ₹413 Cr 📈 Strong Q3 with 108% profit jump & 31% EBITDA margin 🧠 Management: Led by MD Anand Desai, the company is expanding into pharma & polymers, launching 17+ new molecules in FY24. 🔮 Future Outlook: Big bets on exports & specialty polymers — guided 30–35% revenue growth in FY26, backed by strong US contracts. Watch out for

moves and news!